封面
市場調查報告書
商品編碼
1696714

全幻燈片影像市場報告:2031 年趨勢、預測與競爭分析

Whole Slide Imaging Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

由於遠端病理學、細胞病理學、免疫組織化學和血液病理學市場的機會,全球全幻燈片成像 (WSI) 市場的未來前景光明。預計 2025 年至 2031 年期間,全球全幻燈片成像市場將以 6.5% 的複合年成長率成長。該市場的主要驅動力是數位病理解決方案的採用率不斷提高、藥物發現研究活動的擴大以及對高效準確診斷的需求不斷增加。

  • Lucintel 預測,在預測期內,掃描器將成為所有技術中成長最快的技術。
  • 根據應用,遠端病理學預計將在預測期內實現最高成長。
  • 根據地區,預計北美將在預測期內實現最高成長。

整個幻燈片成像市場的策略性成長機會

整個幻燈片成像市場提供了眾多策略性成長機會,可以顯著改善診斷業務和患者治療結果。隨著技術的不斷進步和醫療保健需求的不斷發展,相關人員可以利用這些機會擴大其影響力並改善其服務。識別這些成長領域並採取行動可以在快速變化的環境中提供永續的競爭優勢。

  • 擴大遠端病理學服務:日益成長的遠端病理學需求為全切片成像提供者提供了一個機會,可以加強他們的遠距離診斷能力,特別是在服務不足的地區,促進專家諮詢,並機會獲得優質護理的機會。
  • 開發人工智慧主導的解決方案:對人工智慧技術的投資將促進更先進的全切片成像平台的開發,從而增強影像分析、自動化診斷過程並提高準確性,有助於滿足對可靠診斷工具日益成長的需求。
  • 與教育機構的合作:與大學和研究中心合作制定培訓計劃和研究舉措將有助於建立一支熟悉全幻燈片成像技術的熟練勞動力隊伍,提高其採用率,並確保其在臨床實踐中有效應用。
  • 優先考慮與電子健康記錄(EHR) 的整合:提高整個幻燈片成像系統和 EHR互通性可以簡化工作流程、改善數據共用,並為病理學家提供對患者病歷的便捷訪問,以改善整體診斷過程。
  • 發展新興市場:拓展新興市場代表著巨大的成長機會。隨著這些地區醫療保健基礎設施的發展,對可以透自訂全幻燈片成像解決的數位病理學解決方案的需求日益成長。

整個幻燈片成像市場充滿了推動創新和改善醫療保健服務的策略性成長機會。透過利用這些機會,相關人員可以為成功做好準備,並為數位病理學的發展做出有意義的貢獻。

全幻燈片成像市場促進因素與挑戰

整個幻燈片成像市場充滿了推動創新和改善醫療保健服務的策略性成長機會。透過利用這些機會,相關人員可以為成功做好準備,並為數位病理學的發展做出有意義的貢獻。

推動整個投影片影像市場發展的因素有:

  • 對數位病理學的需求不斷增加:隨著醫療保健提供者尋求改善患者治療結果並簡化工作流程,對高效、準確的診斷工具的需求不斷成長,推動了 WSI 的採用。
  • 技術進步:影像處理技術的不斷進步,例如更高的解析度和更好的分析軟體,正在提高 WSI 系統的功能,並使其對尋求有效解決方案的醫療機構具有吸引力。
  • 監管部門的核准和支持:FDA(美國食品藥物管理局)等監管機構對 WSI 技術的核准不斷增加,這增加了醫療保健專業人士的信心,並鼓勵對數位病理學的投資,從而加速了市場成長。
  • 整合人工智慧:人工智慧與 WSI 系統的整合正在徹底改變診斷方式,實現更快、更準確的影像分析,使病理學家能夠做出更明智的決策,並改善整體患者照護。
  • 遠端醫療的普及率不斷提高:遠端醫療的普及率不斷提高,尤其是在疫情遠端醫療,這推動了對遠距病理學解決方案的需求,使 WSI 成為遠距諮詢和改善專科護理服務的重要工具。

整個幻燈片影像市場面臨的挑戰如下:

  • 前期成本高:採用 WSI 系統的高成本可能會成為許多醫療機構廣泛採用該系統的重大障礙,尤其是預算有限的小型醫療機構。
  • 資料隱私問題:由於 WSI 依賴敏感患者資訊的數位儲存和共用,資料隱私和安全問題可能是一個挑戰,需要採取嚴格的措施來保護患者的隱私。
  • 與現有系統的整合:將 WSI 技術與現有實驗室和醫院資訊系統整合可能很複雜,需要額外的培訓和資源才能確保無縫運​​作。

整個幻燈片成像市場具有強勁的成長動力和挑戰。應對這些挑戰並利用促進因素將使相關人員能夠最佳化他們的策略並有助於成功採用數位病理解決方案。

目錄

第1章執行摘要

第2章全球全幻燈片成像市場:市場動態

  • 簡介、背景和分類
  • 供應鏈
  • 產業驅動力與挑戰

第3章市場趨勢與預測分析(2019-2031)

  • 宏觀經濟趨勢(2019-2024)及預測(2025-2031)
  • 全球全幻燈片成像市場趨勢(2019-2024 年)和預測(2025-2031 年)
  • 全球全幻燈片成像市場(按技術)
    • 掃描器
    • IT基礎設施
    • 檢視器
    • 影像管理系統
  • 全球全幻燈片成像市場(按應用)
    • 遠距病理學(遠端病理診斷)
    • 細胞病理學
    • 免疫組織化學
    • 血液病理學
    • 其他
  • 全球全幻燈片成像市場(按最終用途分類)
    • 學術機構
    • 研究
    • 其他

第4章區域市場趨勢與預測分析(2019-2031)

  • 全球全幻燈片成像市場(按地區)
  • 北美全幻燈片成像市場
  • 歐洲全幻燈片成像市場
  • 亞太全幻燈片成像市場
  • 世界其他地區整體幻燈片成像市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球全幻燈片成像市場成長機會(按技術)
    • 全球全幻燈片成像市場的成長機會(按應用)
    • 全球全幻燈片成像市場成長機會(按最終用途分類)
    • 全球全幻燈片成像市場各區域成長機會
  • 全球全幻燈片成像市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球全幻燈片成像市場的產能擴張
    • 全球全幻燈片成像市場的企業合併
    • 認證和許可

第7章主要企業簡介

  • Olympus Corporation
  • Koninklijke Philips
  • Leica Microsystems
  • Nikon Corporation
  • Visiopharm
  • 3Dhistech
  • Hamamatsu Photonics KK
  • Indica Labs
  • Mikroscan Technologies
  • Akoya Biosciences
簡介目錄

The future of the global whole slide imaging market looks promising with opportunities in the telepathology, cytopathology, immunohistochemistry, and hematopathology markets. The global whole slide imaging market is expected to grow with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing adoption of digital pathology solutions, expanding research activities of drug discovery, and the rising need for efficient and accurate diagnosis.

  • Lucintel forecasts that, within the technology category, scanner is expected to witness the highest growth over the forecast period.
  • Within the application category, telepathology is expected to witness the highest growth over the forecast period.
  • In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Whole Slide Imaging Market

The whole slide imaging market is evolving rapidly, influenced by technological advancements and changing healthcare needs. As the demand for efficient and accurate diagnostic solutions grows, several trends are shaping the future of whole slide imaging. These trends reflect the integration of artificial intelligence, improved workflow efficiencies, and increased accessibility of digital pathology.

  • Integration of Artificial Intelligence: The incorporation of AI algorithms in whole slide imaging is enhancing diagnostic accuracy and speed, enabling pathologists to identify abnormalities more effectively and reducing the potential for human error.
  • Cloud-Based Solutions: The shift toward cloud-based storage and analysis is allowing greater data accessibility and collaboration among healthcare professionals, making it easier to share and review slides remotely, thus streamlining workflows.
  • Telepathology Adoption: The rise of telepathology is transforming how pathology services are delivered, particularly in remote or underserved areas, facilitating consultations and second opinions through digital slide sharing, which enhances patient care.
  • Regulatory Support: Increasing regulatory approvals for whole slide imaging technologies by bodies like the FDA are driving market growth. These approvals foster confidence in digital pathology solutions and encourage healthcare institutions to adopt these innovations.
  • Educational Initiatives: Growing emphasis on educational programs and training for pathologists on whole slide imaging technology is crucial. As professionals become more familiar with digital tools, the adoption rate is expected to rise, promoting better diagnostic practices.

The whole slide imaging market is poised for significant advancements driven by these emerging trends. As technology continues to evolve, stakeholders in healthcare are likely to see enhanced diagnostic capabilities and improved patient outcomes, marking a new era in pathology.

Recent Developments in the Whole Slide Imaging Market

The whole slide imaging market is experiencing rapid advancements, driven by technological innovations, regulatory changes, and increased adoption in clinical settings. These developments are reshaping the landscape of digital pathology, making diagnostic processes more efficient and accurate. As healthcare continues to evolve, key milestones highlight the potential of whole slide imaging to transform pathology practices and improve patient care.

  • Increased AI Integration: Recent advancements in artificial intelligence are enhancing whole slide imaging applications, with algorithms now capable of analyzing slides for complex patterns, thereby supporting pathologists in diagnostics and improving accuracy and speed.
  • Expansion of Regulatory Approvals: Regulatory bodies, such as the FDA, are increasingly approving whole slide imaging systems for clinical use. These approvals not only validate the technology's reliability but also encourage healthcare facilities to invest in digital pathology solutions.
  • Advancements in Image Analysis Software: The development of sophisticated image analysis software is enabling more detailed examination of whole slide images, allowing pathologists to extract valuable insights and supporting more informed clinical decisions based on enhanced visualization.
  • Growth of Remote Pathology Services: The demand for remote pathology services is on the rise, particularly following the pandemic. Whole slide imaging technology is facilitating telepathology, enabling specialists to provide consultations and diagnostics from distant locations efficiently.
  • Increased Investment in Research: Significant investments in research and development by both public and private sectors are driving innovation in whole slide imaging technologies. These funds are aimed at enhancing functionality, improving interoperability, and advancing education in digital pathology.

Recent developments in the whole slide imaging market reflect a dynamic evolution in the field of pathology. With ongoing innovations and growing acceptance among healthcare professionals, whole slide imaging is set to play a pivotal role in transforming diagnostic practices and enhancing patient outcomes in the coming years.

Strategic Growth Opportunities for Whole Slide Imaging Market

The whole slide imaging market presents numerous strategic growth opportunities that can significantly enhance diagnostic practices and patient outcomes. As technology continues to advance and healthcare needs evolve, stakeholders can leverage these opportunities to expand their reach and improve services. Identifying and acting on these growth areas can lead to sustained competitive advantages in a rapidly changing landscape.

  • Expanding Telepathology Services: The growing need for telepathology offers an opportunity for whole slide imaging providers to enhance remote diagnostic capabilities, particularly in underserved regions, facilitating expert consultations and improving access to quality healthcare.
  • Development of AI-Driven Solutions: Investing in AI technologies can enable companies to create more advanced whole slide imaging platforms that enhance image analysis, automate diagnostic processes, and improve accuracy, thereby meeting the increasing demand for reliable diagnostic tools.
  • Collaboration with Educational Institutions: Partnering with universities and research centers to develop training programs and research initiatives can foster a skilled workforce familiar with whole slide imaging technology, promoting its adoption and ensuring effective utilization in clinical practice.
  • Focus on Integration with Electronic Health Records (EHR): Enhancing interoperability between whole slide imaging systems and EHRs can streamline workflows, improve data sharing, and ensure that pathologists have immediate access to patient histories, thereby enhancing the overall diagnostic process.
  • Exploring Emerging Markets: Expanding operations into emerging markets presents a significant growth opportunity. As healthcare infrastructure develops in these regions, there is a rising demand for digital pathology solutions, which can be met with tailored whole slide imaging offerings.

The whole slide imaging market is ripe with strategic growth opportunities that can drive innovation and improve healthcare delivery. By capitalizing on these avenues, stakeholders can position themselves for success and make meaningful contributions to the evolution of digital pathology.

Whole Slide Imaging Market Driver and Challenges

The whole slide imaging market is ripe with strategic growth opportunities that can drive innovation and improve healthcare delivery. By capitalizing on these avenues, stakeholders can position themselves for success and make meaningful contributions to the evolution of digital pathology.

The factors responsible for driving the whole slide imaging market include:

  • Increasing Demand for Digital Pathology: The rising need for efficient and accurate diagnostic tools is driving the adoption of WSI, as healthcare providers seek to improve patient outcomes and streamline workflow processes.
  • Advancements in Technology: Continuous advancements in imaging technology, including higher resolution and better analysis software, are enhancing the capabilities of WSI systems, making them more appealing to medical institutions looking for effective solutions.
  • Regulatory Approvals and Support: Growing regulatory approvals for WSI technologies from agencies like the FDA are fostering trust and encouraging healthcare providers to invest in digital pathology, thereby accelerating market growth.
  • Integration of Artificial Intelligence: The integration of AI into WSI systems is revolutionizing diagnostics by enabling faster and more accurate image analysis, helping pathologists make informed decisions, and improving overall patient care.
  • Expanding Telemedicine Adoption: The increased acceptance of telemedicine, particularly post-pandemic, is driving demand for telepathology solutions, making WSI an essential tool for remote consultations and enhancing access to expert care.

Challenges in the whole slide imaging market are:

  • High Initial Costs: The high costs associated with implementing WSI systems can be a significant barrier for many healthcare facilities, especially smaller institutions with limited budgets, which may hinder widespread adoption.
  • Data Privacy Concerns: As WSI relies on digital storage and sharing of sensitive patient information, concerns about data privacy and security can pose challenges, requiring stringent measures to protect patient confidentiality.
  • Integration with Existing Systems: The complexity of integrating WSI technology with existing laboratory and hospital information systems can create operational hurdles, necessitating additional training and resources to ensure seamless functionality.

The whole slide imaging market is characterized by strong growth drivers and notable challenges. By addressing these challenges while capitalizing on the drivers, stakeholders can optimize their strategies and contribute to the successful implementation of digital pathology solutions.

List of Whole Slide Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies whole slide imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the whole slide imaging companies profiled in this report include-

  • Olympus Corporation
  • Koninklijke Philips
  • Leica Microsystems
  • Nikon Corporation
  • Visiopharm
  • 3Dhistech
  • Hamamatsu Photonics KK
  • Indica Labs
  • Mikroscan Technologies
  • Akoya Biosciences

Whole Slide Imaging by Segment

The study includes a forecast for the global whole slide imaging market by technology, application, end use, and region.

Whole Slide Imaging Market by Technology [Analysis by Value from 2019 to 2031]:

  • Scanners
  • IT Infrastructure
  • Viewer
  • Image Management System

Whole Slide Imaging Market by Application [Analysis by Value from 2019 to 2031]:

  • Telepathology
  • Cytopathology
  • Immunohistochemistry
  • Hematopathology
  • Others

Whole Slide Imaging Market by End Use [Analysis by Value from 2019 to 2031]:

  • Academic Institute
  • Research
  • Others

Whole Slide Imaging Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Whole Slide Imaging Market

The whole slide imaging market has witnessed significant growth recently, driven by advancements in digital pathology, increasing adoption of telepathology, and rising demand for efficient diagnostic tools. This technology enhances the accuracy of pathology assessments, facilitates remote consultations, and supports educational initiatives. As the market evolves, key players are expanding their offerings and exploring innovative solutions. This report highlights recent developments in the whole slide imaging market across the United States, China, Germany, India, and Japan.

  • United States: The U.S. market is rapidly expanding due to increased investments in healthcare technology and regulatory approvals, with companies focusing on enhancing AI integration to improve diagnostic accuracy and workflow efficiency.
  • China: The Chinese whole slide imaging market is experiencing robust growth, fueled by government initiatives to modernize healthcare, coupled with rising demand for digital solutions among hospitals and laboratories, as well as significant investments in research and development.
  • Germany: Germany is at the forefront of whole slide imaging technology in Europe, driven by strong research institutions and healthcare partnerships. Ongoing regulatory support and funding for innovative solutions are further propelling the market's expansion.
  • India: The Indian whole slide imaging market is gaining momentum as healthcare facilities adopt digital pathology solutions. Increasing awareness of the benefits of whole slide imaging among pathologists and educational institutions is encouraging growth in this sector.
  • Japan: Japan is leveraging its advanced technology landscape to enhance whole slide imaging applications. The government's focus on digital transformation in healthcare is fostering collaborations between tech companies and medical institutions to improve diagnostic processes.

Features of the Global Whole Slide Imaging Market

Market Size Estimates: Whole slide imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Whole slide imaging market size by technology, application, end use, and region in terms of value ($B).

Regional Analysis: Whole slide imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, applications, end uses, and regions for the whole slide imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the whole slide imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the whole slide imaging market by technology (scanners, IT infrastructure, viewer, and image management system), application (telepathology, cytopathology, immunohistochemistry, hematopathology, and others), end use (academic institute, research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Whole Slide Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Whole Slide Imaging Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Whole Slide Imaging Market by Technology
    • 3.3.1: Scanners
    • 3.3.2: IT Infrastructure
    • 3.3.3: Viewer
    • 3.3.4: Image Management System
  • 3.4: Global Whole Slide Imaging Market by Application
    • 3.4.1: Telepathology
    • 3.4.2: Cytopathology
    • 3.4.3: Immunohistochemistry
    • 3.4.4: Hematopathology
    • 3.4.5: Others
  • 3.5: Global Whole Slide Imaging Market by End Use
    • 3.5.1: Academic Institute
    • 3.5.2: Research
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Whole Slide Imaging Market by Region
  • 4.2: North American Whole Slide Imaging Market
    • 4.2.1: North American Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
    • 4.2.2: North American Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
  • 4.3: European Whole Slide Imaging Market
    • 4.3.1: European Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
    • 4.3.2: European Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
  • 4.4: APAC Whole Slide Imaging Market
    • 4.4.1: APAC Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
    • 4.4.2: APAC Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
  • 4.5: ROW Whole Slide Imaging Market
    • 4.5.1: ROW Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
    • 4.5.2: ROW Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Whole Slide Imaging Market by Technology
    • 6.1.2: Growth Opportunities for the Global Whole Slide Imaging Market by Application
    • 6.1.3: Growth Opportunities for the Global Whole Slide Imaging Market by End Use
    • 6.1.4: Growth Opportunities for the Global Whole Slide Imaging Market by Region
  • 6.2: Emerging Trends in the Global Whole Slide Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Whole Slide Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Whole Slide Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Olympus Corporation
  • 7.2: Koninklijke Philips
  • 7.3: Leica Microsystems
  • 7.4: Nikon Corporation
  • 7.5: Visiopharm
  • 7.6: 3Dhistech
  • 7.7: Hamamatsu Photonics KK
  • 7.8: Indica Labs
  • 7.9: Mikroscan Technologies
  • 7.10: Akoya Biosciences